Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publicationmore...
As of March 2026 65.99% is owned by Indian Promoters and 34.01% by Public. Top four Promoters holding highest number of shares of Balaxi Pha...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period...more...
BALAXI PHARMACEUTICALS LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Boar...more...
Ashish Maheshwari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantia...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange in order to ensure that investors have latest relevan...more...
Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange in order to ensure that investors have lates...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Credit Rating- Revisionmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradi...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Balaxi Pharmaceuticals Limited has informed the Exchange regarding Intimation of K...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Appointment of Mr AMAN PUROHIT as Company Secretary & Compliance Officer ...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about change in Managementmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Change in Company Secretary/Compliance Officermore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on March 25 2026.more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentationmore...
The company reported standalone net profit of Rs 1.53 crore for the quarter ended December 31 2025 as compared to Rs 1.74 crore in the same period la...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32more...
BOARD MEETINGS Company Name : Aditya Birla Real Date : 06-05-2026